Guidelines for the use of GnRH-Analogues in the treatment of endometriosis;Leitlinien für den einsatz der GnRH-Agonisten zur behandlung der endometriose

Zentralblatt fur Gynakologie

Volumn 127, Issue 5, 2005, Pages 308-313

  Schweppe, K W ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Endometriosis; GnRH Analogues; Medical therapy of endometriosis

Indexed keywords

GONADORELIN DERIVATIVE;

ENDOMETRIOSIS; HUMAN; PRACTICE GUIDELINE; REVIEW; SIDE EFFECT;

ENDOMETRIOSIS; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS;

EID: 25844433574     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-836865     Document Type: Review

References (53)

1. Abbott JA, Hawe J, Clayton RD, Carry R. The effects and effectiveness of laparoscopic excision of endometriosis: a prospective study with 2-5 year follow up. Hum Reprod 2003; 18: 1222-1227
2. Barhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometriosis on in vitro fertilisation. Fertil Steril 2002; 77: 1148-1155
3. Bianchi S, Busacca M, Agnoli B et al. Effects of 3 months therapy with danazol after laparoscopic surgery for stage III/IV endometriosis: a randomised study. Hum Reprod 1999; 14: 1335-1337
4. Busacca M, Somigliana E, Bianchi S et al. Post-operative GnRH analogue treatment after conservative surgery for symptomatic endometriosis stage III-IV: a randomised controlled trial. Hum Reprod 2001; 16:2399-2402
5. Donnez J, Nisolle M, Gillerot S et al. Ovarian endometrial cysts: the role of gonadotropin-releasing hormone agonist and/or drainage. Fertil Steril 1994; 62: 63-66
6. Donnez J, Nisolle M, Smoes P et al. Peritoneal endometriosis and "endometriotic" nodules of the rectovaginal septum are two different entities. Fertil Steril 1996; 66: 362-368
7. Ebert AD, Bartley J, David S et al. Aromatasehemmer - theoretisches Konzept und bisherige Erfahrungen in der Endometriosetherapie. Zentralbl Gynäkol 2003; 125: 243-246
8. Evers JL The second-look laparoscopy for evaluation of the result of medical treatment of endometriosis should not be performed during ovarian suppression. Fertil Steril 1987; 47: 502-504
9. Freundl G, Gödtke K, Gnoth C et al. Steroidal 'add-back' therapy in patients treated with GnRH agonists. Gynaecol Obstet Invest 1998; 45: 22-30
10. Hemmings R. Combined treatment of endometriosis. GnRH agonists and laparoscopic surgery. J Reprod Med 1998; 43: 316-320
11. Hippach M, Hinrichs I, Schweppe KW. Möglichkeiten der Langzeittherapie bei rezidivierender Endometriose. Zentralbl Gynäkol 2003; 125: 303
12. Hornstein MD, Yuzpe AA, Burry KA et al. Prospective randomised double-blind trial of 3 versus 6 months of narfarelin therapy for endometriosis associated pelvic pain. Fertil Steril 1995; 63: 955-962
13. Hornstein MD, Hemmings R, Yuzpe AA et al. Use of narfarelin versus placebo after reductive laparoscopic surgery for endometriosis. Fertil Steril 1997; 68: 860-864
14. Hughes E, Fedorkow D, Collins J et al. Ovulation suppression for endometriosis (Cochrane Review). In: The Cochrane Library, Issue 3. John Wiley & Sons Ltd, Chichester, UK 2004
15. Irahara M, Uemura H, Yasui T et al. Efficacy of every-other-day administration of conjugated equine estrogen and medroxyprogesterone acetate on gonadotropin-releasing hormone agonists treatment in women with endometriosis. Gynaecol Obstet Invest 2001; 52: 217-222
16. Jansen RP, Russell P. Nonpigmented endometriosis: clinical, laparoscopic, and pathologic definition. Am J Obstet Gynecol 1986; 155: 1154-1159
17. Kampe D, Sahl AC, Schweppe KW. Prä- und postoperative Endometriosetherapie mit GnRH-Agonisten in Depotform: drei- versus sechsmonatige Behandlungsdauer. Zentralbl Gynäkol 2003; 125: 304
18. Kennedy S, Bergqvist A, Chapron C et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod. 2005; in press
19. Kiesel L, Schweppe K-W, Sillem M et al. Should add-back therapy for endometriosis be deferred for optimal results? Br J Obst Gynaecol 1996; 103: 15-17
20. Lee PA, Houk CP. Outcome among adult females after treatment of central precocious puberty (CPP) with GnRH analogue (GnRH-A). 8th International Symposium on GnRH-Analogues 2005; abstract 68
21. Malik E, Berg C, Meyhöfer-Malik A et al. Fluorescence diagnosis of endometriosis using 5-aminolevulinic acid. Surg Endosc 2000; 4: 452-455
22. Malinak LR. Surgical treatment and adjunct therapy of endometriosis. Int J Gynaecol Obstet 1993; 40: S43-S47
23. Marcoux S, Maheux R, Berube S. Laparoscopic surgery in infertile women with minimal or mild endometriosis. Canadian Collaborative Group on Endometriosis. N Engl J Med 1997; 337: 217-222
24. Meldrun DR, Chang RJ, Lu J et al. Medical oophorectomy using a long-acting GnRH agonist: a possible new approach to the treatment of endometriosis. J Clin Endocrinol Metab 1982; 54: 1081-1083
25. Mori H, Taketani Y, Uemura T et al. Rates of endometriosis recurrence and pregnancy 1 year after treatment with intranasal buserelin acetate (Suprecur) (a prospective study). J Obst Gynaecol Res 1999; 25: 153-164
26. Muzii L, Marana R, Caruana P et al. The impact of preoperative gonadotropin-releasing hormone agonist treatment on laparoscopic excision of ovarian endometriotic cysts. Fertil Steril 1996; 65: 1235-1237
27. Muzii L, Marana R, Caruana P et al. Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: a prospective, randomised trial. Am J Obstet Gynecol 2000; 183: 588-592
28. Parazzini F. Ablation of lesions or no treatment in minimal-mild endometriosis in infertile women: a randomised trial. Gruppo Italiano per lo Studio dell' Endometriosi. Hum Reprod 1999; 14: 1332-1334
29. Prentice A, Deary AJ, Bland E. Progestagens and anti-progestagens for pain associated with endometriosis. In: The Cochrane Library, Issue 3. John Wiley & Sons Ltd, Chichester 2003
30. Radwanska E. The effect of GnRH Agonist suppression on the outcome of infertility treatment in women with endometriosis. 5th International Symposium on GnRH Analogues: Geneva 1999; abstract 86
31. Regidor PA, Regidor M, Ruwe B et al. Prospective randomised study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis. Gynecol Endocrinol 2001; 15: 202-209
32. Regidor PA, Wagner I, Ruwe M et al. Morphometric analyses of endometriotic tissues to determine their grade of activity. Gynecol Endocrinol 2002; 16: 235-243
33. Regidor PA. GnRH-Agonists and endometriosis: comparison of nasal spray and depot formulations. 8th International Symposium on GnRH-Analogues 2005; abstract 60
34. Rickes D, Nickel I, Kropf S et al. Increased pregnancy rates after ultra long postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis. Fertil Steril 2002; 78: 757-762
35. Rickes D, Weiß M, Nickel I et al. Ovarielle Ansprechbarkeit auf rekombinante Gonadotropine nach ultralanger "Dornregulation" mit GnRH-Analoga. Zentralbl Gynäkol 2003; 125: 306
36. Ruwe M, Donhuijsen K, Regidor PA et al. Endometriose: Klinische, histologische und morphometrische Befunde vor und nach Gn-RH-Agonisten-Therapie. Zentralbl Gynäkol 1998; 120: 391-398
37. Schindler AE, Förtig P, Kienle E et al. Early treatment of endometriosis with GnRH-agonists: impact on time to recurrence. Europ J Obst Gynec Reprod Biol 2000; 93: 123-125
38. Schweppe K-W. Klinik und Morphologie der Endometriose. Schattauer Verlag, Stuttgart, New York 1984
39. Schweppe K-W. Aktive - inaktive Endometriose - eine prognose- und therapierelevante Differentialdiagnose. Zentralbl Gynäkol 1999; 121: 330-335
40. Schweppe K-W, Ring D. Peritoneal defects and the development of endometriosis in relation to the timing of endoscopie surgery during the menstrual cycle. Fertil Steril 2002; 78: 763-766
41. Schweppe K-W. The use of GnRH analogues before and after surgery for endometriosis - clinical problems and experiences. 8th International Symposium on GnRH-Analogues 2005; abstract 37
42. Shaw RW. The role of GnRH analogues in the treatment of endometriosis. Br J Obst Gynaecol 1992; 99: 9-12
43. Surrey ES, Hornstein MD. Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long term follow up. Obstet Gynecol 2002; 99: 709-719
44. Surrey ES, Silverberg KM, Surrey MW et al. Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilisation-embryo transfer in patients with endometriosis. Fertil Steril 2002; 78: 699-704
45. Sutton CJG, Ewen SP, Whitelaw N. Prospective, randomised, double-blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild and moderate endometriosis. Fertil Steril 1994; 62: 696-700
46. Templeton A, Morris JK, Parslow W. Factors that affect outcome of invitro fertilisation treatment. Lancet 1996; 348: 1402-1406
47. Tinneberg H-R, Manolopoulos K. Reproductive medicine: comparison of depot formulations of GnRH-Agonists, daily injections and nasal spray. 8th International Symposium on GnRH-Analogues 2005; abstract 59
48. Uemura T, Shirasu K, Katagiri N et al. Low-dose GnRH agonist therapy for the management of endometriosis. J Obstet Gynaecol Res 1999; 25: 295-301
49. Uemura T, Yoshikata H, Ishikawa M et al. Effects of pre-treatment with GnRH-Agonists on bone mineral density in patients with endometriosis. 5th International Symposium on GnRH-Analogues 1999; abstract 45
50. Vercellini P, Crosignani PG, Fadini R et al. A gonadotropin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis. Br J Obstet Gynaecol 1999; 106: 672-677
51. Waller KG, Shaw RW. Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up. Fertil Steril 1993; 59: 511-515
52. Zeitoun KM, Bulun SE. Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target. Fertil Steril 1999; 72: 961-969
53. Zupi E, Marconi D, Sbracia M et al. Add-back therapy in the treatment of endometriosis-associated pain. Fertil Steril 2004; 82: 1303-1308